PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Abstract

We have previously shown that dysregulation of miR-21 functioned as an oncomiR in breast cancer. The aim of the present study was to elucidate the mechanisms by which miR-21 regulate breast tumor migration and invasion. We applied pathway analysis on genome microarray data and target-predicting algorithms for miR-21 target screening, and used luciferase reporting assay to confirm the direct target. Thereafter, we investigated the function of the target gene phosphoinositide-3-kinase, regulatory subunit 1 (α) (PIK3R1), and detected PIK3R1 coding protein (p85α) by immunohistochemistry and miR-21 by RT-qPCR on 320 archival paraffin-embedded tissues of breast cancer to evaluate the correlation of their expression with prognosis. First, we found that PIK3R1 suppressed growth, invasiveness, and metastatic properties of breast cancer cells. Next, we identified the PIK3R1 as a direct target of miR-21 and showed that it was negatively regulated by miR-21. Furthermore, we demonstrated that p85α overexpression phenocopied the suppression effects of antimiR-21 on breast cancer cell growth, migration and invasion, indicating its tumor suppressor role in breast cancer. On the contrary, PIK3R1 knockdown abrogated antimiR-21-induced effect on breast cancer cells. Notably, antimiR-21 induction increased p85α, accompanied by decreased p-AKT level. Besides, antimiR-21/PIK3R1-induced suppression of invasiveness in breast cancer cells was mediated by reversing epithelial-mesenchymal transition (EMT). p85α downregulation was found in 25 (7.8%) of the 320 breast cancer patients, and was associated with inferior 5-year disease-free survival (DFS) and overall survival (OS). Taken together, we provide novel evidence that miR-21 knockdown suppresses cell growth, migration and invasion partly by inhibiting PI3K/AKT activation via direct targeting PIK3R1 and reversing EMT in breast cancer. p85α downregulation defined a specific subgroup of breast cancer with shorter 5-year DFS and OS, which may require more aggressive treatment.

Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma

“…Phosphoinositide-3-kinase regulatory subunit 1(PIK3R1) binds, stabilizes and inhibits the PI3K p110 catalytic subunit [39]. Previous studies show that PIK3R1 suppresses tumor cell invasion and migration by reducing PI3K/AKT signaling [40]. In this study, ITGB1, HIF1A, and PIK3R1 were selected as core mRNAs with important function in advanced LSCC.…”

Exosome‑mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR‑21

“…It has been demonstrated that miR-21 positively regulates the PI3K/Akt signaling pathway (18,36,37). miR-21 suppresses tumor cell migration and invasion by reducing PI3K/Akt signaling and reversing the epithelial-mesenchymal transition in breast cancer (36). miR-21 also modulates the radiosensitivity of cervical cancer by inhibiting autophagy via the Akt-mTOR signaling pathway (37).…”

Cross-Sectional Study of Gene Expression Analysis Identifies Critical Biological Pathways and Key Genes Implicated in Non-Small Cell Lung Cancer

“…The current results further proved the role of CDK1 in NSCLC, and CDK1 was the key gene in the PPI network. At present, PIK3R1 has been proved to be a double-sided factor in different cancers, and was a positive regulator in breast and endometrial cancers (41,42) and was a negative regu-…”